MLM Ranks

LifeVantage CEO Terrence Moorehead Appointed 2026

LifeVantage Appoints Terrence Moorehead as New President and CEO

SALT LAKE CITY, UT – April 20, 2026 –  LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company specializing in cellular-level health activation, today announced the appointment of Terrence Moorehead as its new President and Chief Executive Officer. He will also join the company’s Board of Directors, effective August 5, 2026.

Mr. Moorehead is expected to begin his role after completing his contractual commitments with his previous employer.

Terrence Moorehead Brings 25+ Years of Leadership Experience

Terrence Moorehead is a seasoned executive with over 25 years of experience in revitalizing brands, driving customer growth, and delivering strong financial results in the direct selling and consumer products industries.

Terrence Moorehead, CEO of LifeVantage, professional business portrait with formal attire

He most recently served as President and Chief Executive Officer of Nature’s Sunshine Products, Inc. from 2018 to 2025. During his tenure, he successfully led a multi-year transformation that increased revenue by 45% and EBITDA by 190%.

Prior to that, Mr. Moorehead held CEO positions at Carlisle Etcetera LLC (2015–2018) and Dana Beauty, Inc. (2013–2015). He also spent over two decades at Avon Products, Inc. in various senior leadership roles, including VP of Strategy and Digital for North America, General Manager of Avon Italy, President of Avon Canada, and Chairman and President of Avon Japan.

LifeVantage Board Praises Moorehead’s Track Record

“Terrence has an outstanding track record of driving growth and scaling global health and wellness brands,” said Raymond Greer, Chairman of the Board of LifeVantage.

“After a comprehensive search, the Board unanimously selected Terrence for his proven ability to lead business transformations and his deep expertise in sales, marketing, and finance. He is the ideal leader to guide LifeVantage into its next chapter of growth.”

Moorehead Expresses Excitement to Join LifeVantage

“I’m honored to join LifeVantage at this pivotal moment,” said Terrence Moorehead.

“The Company’s science-backed products, passionate consultant community, and dedicated employees form a strong foundation for future success. I look forward to working with the Board and the entire team to sharpen our strategy, drive sustainable growth, and deliver long-term value for stockholders.”

Leadership Transition Details

The retirement of current President and CEO Steve Fife will take effect on April 30, 2026. To ensure a smooth transition, the Board has appointed current director Michael Beindorff as Interim CEO. He will be supported by Executive Advisors Kristen Cunningham, Chief Sales Officer, and Carl Aure, Chief Financial Officer, until Terrence Moorehead assumes the role.

Gratitude for Steve Fife’s Contributions

Raymond Greer added, “On behalf of the Board, we thank Steve Fife for his nine years of dedicated leadership. His vision helped modernize our business model, strengthen our financial position, expand our product portfolio, and grow our international presence. We wish him all the best in his retirement.”

The interim leadership team brings deep experience and commitment to maintaining business continuity for employees, consultants, and customers during this transition.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in nutrigenomics – the science of how nutrition activates your genes for better health. The company develops scientifically validated products that work with your body’s natural processes to support optimal health at the cellular level.

Its flagship products include the Protandim® family, TrueScience® Liquid Collagen, the MindBody GLP-1 System™, P84 gut activator, and a full range of activation-supporting supplements, skincare, haircare, and pet products.

RELATED ARTICLES

Reviews:

There are no reviews yet. Be the first one to write one.

Leave Your Review Here:

MLM Ranks YouTube channel disclaimer outlining general info, no financial advice, earnings disclaimer, and copyright notice.